Perrigo | PRGO - Cost Of Sales


Perrigo reported $747.4M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Abbott USD 4.92B 535M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Coherus Biosciences USD 2.65M 31.2M Mar/2025
Corcept Therapeutics USD 2.54M 2.05M Dec/2025
Dr.Reddys Laboratories INR 36.16B 3.75B Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
J&J USD 7.97B 689M Dec/2025
Merck USD 3.32B 531M Dec/2025
Nestle CHF 23.61B 1.27B Jun/2025
Pacira USD 54.62M 6.02M Dec/2025
Perrigo USD 747.4M 81.2M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Phibro Animal Health USD 207.39M 30.45M Dec/2024
Prestige Brands USD 131.22M 3.52M Dec/2025
Reckitt Benckiser GBP 2.75B 1.34B Dec/2024
Sanofi EUR 4.29B 421M Dec/2025
Supernus Pharmaceuticals USD 47.53M 4.24M Dec/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025
Xeris Pharmaceuticals USD 13.71M 1.81M Sep/2025
Zoetis USD 743M 60M Dec/2025